About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.
Monthly Archives: June 2023
It Finally Happened – FDA’s OPDP Issues First Letter of 2023
For those who are regular followers of what FDA’s Office of Prescription Drug Promotion (OPDP) is up to, there was a surprise this week when the office posted the first regulatory action letter – in this case an Untitled Letter … Continue reading
Posted in Warning Letters
Tagged #DTC, #OPDP, #pharma, #Warning Letter
Comments Off on It Finally Happened – FDA’s OPDP Issues First Letter of 2023